Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

2(29%)

Results Posted

40%(2 trials)

Phase Distribution

Ph phase_2

14%

Ph not_applicable

57%

Ph phase_4

29%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 2Efficacy & side effects

1(14.3%)

Phase 4Post-market surveillance

2(28.6%)

N/ANon-phased studies

4(57.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(5)

Detailed Status

Completed5

Recruiting2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (14.3%)

Phase 42 (28.6%)

N/A4 (57.1%)

Trials by Status

recruiting229%

completed571%

Recent Activity

2 active trials

Showing 5 of 7

recruitingnot_applicable

Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury

NCT05805683

recruitingphase_4

Clinical Trials (7)

Showing 7 of 7 trials

NCT05805683Not Applicable

Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury

Recruiting

NCT03935984Phase 4

Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity

Recruiting

NCT03342001Phase 4

Hypothyroidism Treated With Calcitonin

Completed

NCT00478335Not Applicable

Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus

Completed

NCT02115360Not Applicable

Epidural Calcitonin in Lower Limb Amputation

Completed

NCT00688077Not Applicable

FGF-23 Suppressibility by Calcitonin

Completed

NCT00004358Phase 2

Phase II Study of Calcitonin for Tumoral Calcinosis

Completed

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7